Microsoft word - document

Pine Heights Medical Center at St. Agnes Hospital Resident and Surgical Intern/Department of Surgery A 58 KD protein related to virulence in Legionella pneumophila:Dr. Michael Hanna, Department of Biology, Rensselaer Polytchnic Ligand-independent activation of the androgen receptor in benign hyperplasia prostate tissue explants with insulin-like growth factor-1 and human growth hormone as determined by prostate specific antigen secretion. Dr. William Rosner, Department of Endocrinology, St. Luke's/Roosevelt Hospital Center, New York, Open Study, Alza Corporation, Clinical Investigator, Urologic Surgery Associates, Towson, MD. A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial to Evaluate the Efficacy And Safety of a Fesoterodine Flexible Dose Regimen in Patients With Overactive Bladder "Post-Marketing Study Using Prolieve for the Treatment of Benign Prostate Hyperplasia (BPH)" A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fesoterodine as a "Add-On" Therapy in Men With Persistent Overactive Bladder Symptoms under Monotherapy of Alpha Blocker for Lower Urinary Tract Symptoms Bioniche Therapeutics Limited Sub-Investigator Open-Label, Multi-Center Study of the Efficacy and Safety of MMC in the Treatment In Patients with Non-Muscle Invasion (Superficial) Bladder Cancer at High Risk of Progression and who are Refractory to BCG Instructor: Introduction to Biology and Cell Biology, Department of Biology, Rensselaer Polytechnic Institute, Troy, NY 2000-2004 Expert Reviewer, Urology, Infectious Disease Category Surgical Policy Committee, Union Memorial Hospital, Baltimore, MD, 2000-2002 Performance Improvement Committee, Howard County General Hospital, Howard County, MD, 2004-2006 Staiman VR, O'Toole KC, Rubin MA, and Lowe FC. Giant malignant fibrous histiocytoma of the testis/spermatic cord: psychological and possible etiologic complications of unethical Nazi medical experimentation. Urology 48 (6): 939-943, 1996. Staiman VR, and Hensle TW. Modified tabularized incised plate urethroplasty: surgical technique and clinical outcome. Current Surgical Techniques in Urology 10: 1-10, 1997. Staiman VR, and Kaplan SA. Therapy for diabetes mellitus and related disorders, Bladder dysfunction. American Diabetes Association for Clinical Education Series, Third Edition, 1998. Staiman VR, and LoweFC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 50: 929-933, 1997. Staiman VR, and Lowe FC. Five Minute Urology Consult. Gynecomastia, 1999. Knowles DR, Staiman VR, and Gupta M. Long-term results of the treatment of complete distal ureteral stenosis using a cutting balloon catheter device. Journal of Urology 166 (6): 2087-2090, 2001. The spectrum of prostate disease in HIV-infected patients: prostatic abscess, and emerging problem. Valentine Essay Contest, New York Academy of Medicine, New York, March 29, 1995. Androgen receptor activation by insulin like growth factor-1 and growth hormone in benign hyperplasia tissue explants in the absence of androgens. Valentine Essay Contest, New York Academy of Medicine, New York, March 26, 1997. The treatment of flutamide and finasteride induced painful gynecomastia with tamoxifen. American Urologic Association, Podium Presentation, New Orleans, LA, April 15, 1997 Techniques of endoscopic ureteroneocystostomy (video presentation).World Congress on Endourology and SWL, New York, NY, September 4, 1998. Anterior trapezoidal bladder neck tube reconstruction produces excellent urinary continence following radical retropubic prostatectomy. American Urologic Association, Poster Presentation #1370. Dallas, TX, 1999. Testicular Cancer. Men's Health Lecture Series, St. Joseph Medical Center, Baltimore, MD, 1999. Diagnosis and treatment of hydronephrosis in the pediatric population. Pediatric Grand Rounds, Union Memorial Hospital, Baltimore, MD, 2001.


Vanoxide® HC Lotion (benzoyl peroxide 5%, hydrocortisone 0.5%) FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE. DESCRIPTION: Each mL of VANOXIDE® HC LOTION contains, as dispensed, 50 mg benzoyl peroxide and 5 mg hydrocortisone in a water washable vanishing lotion of BHA/BHT, caprylic/capric triglyceride, cetyl alcohol, decyl oleate, dibasic sodium phosphate, dical-

Allergy history

Texas Sinus Center ALLERGY TESTING INFORMATION 1. On the day of testing please wear a short-sleeved shirt that can be pushed up comfortably to your shoulder. Allow 1-2 hours for your test session. You will need to stay on the premises during this time. Please do not bring children to your appointment. 2. Remember to STOP TAKING ANTIHISTAMINES and DECONGESTANTS at least 5 days before your

© 2010-2014 Pdf Medical Search